vidarabine phosphate has been researched along with Carcinoma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Biagiotti, S; De Marco, C; Dominici, S; Magnani, M; Orlotti, N; Pierigè, F; Rossi, L; Serafini, S; Zaffaroni, N | 1 |
Belt, RJ; Coltman, CA; Costanzi, JJ; Crowley, J; Hynes, HE; Taylor, SA; Von Hoff, DD; Weiss, GR | 1 |
Coltman, CA; Fleming, TR; Harvey, WH; Katterhagen, JG; Von Hoff, DD | 1 |
3 other study(ies) available for vidarabine phosphate and Carcinoma
Article | Year |
---|---|
Cytotoxic activity of 2-Fluoro-ara-AMP and 2-Fluoro-ara-AMP-loaded erythrocytes against human breast carcinoma cell lines.
Topics: Antineoplastic Agents; Apoptosis; Arabinonucleotides; Breast Neoplasms; Carcinoma; Cell Line, Tumor; Cell Proliferation; Cytotoxins; DNA, Neoplasm; Drug Delivery Systems; Drug Evaluation, Preclinical; Erythrocytes; Female; Flow Cytometry; Humans; Time Factors; Vidarabine Phosphate | 2010 |
Phase II study of fludarabine phosphate for the treatment of advanced non-small cell carcinoma of the lung: a Southwest Oncology Group Study.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Arabinonucleotides; Carcinoma; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Vidarabine Phosphate | 1986 |
Phase II study of fludarabine phosphate in previously untreated patients with colorectal carcinoma: a Southwest Oncology Group Study.
Topics: Adult; Aged; Arabinonucleotides; Carcinoma; Colonic Neoplasms; Drug Evaluation; Humans; Middle Aged; Rectal Neoplasms; Vidarabine Phosphate | 1987 |